HOME >> MEDICINE >> NEWS
Researchers confirm Vioxx nearly doubled cardiovascular risks in cancer prevention study

HOUSTON - The largest prospective trial ever examining the anti-inflammatory drug Vioxx as a chemoprevention agent found that the risk of developing a cardiovascular "event" - heart attacks and/or strokes - was almost double in patients who received the drug, compared to patients who took the placebo, according to a study out Feb. 15 on-line in The New England Journal of Medicine.

The risk was first discovered and reported last September by the study's safety monitoring board and led to the shutdown of the colon cancer chemoprevention trial and subsequent withdrawal of the drug from the U.S. market.

The trial, known as APPROVe (Adenomatous Polyp Prevention on Vioxx), was the longest test yet of Vioxx as a chemoprevention agent, and was designed to determine whether the drug could prevent the re-growth of precancerous colon polyps in people who had already had polyps removed. The prospective chemoprevention study randomized 2,586 participants from 108 centers in 29 countries to receive either 25 mgs. of Vioxx daily or a placebo drug for three years, 2001-2004. The trial was stopped September 30, 2004 - approximately two months before its planned completion.

According to Robert S. Bresalier, M.D., of The University of Texas M. D. Anderson Cancer Center and lead author of The New England Journal of Medicine study, 46 of the 1287 patients randomized to take Vioxx daily had confirmed cardiovascular events over a three year period - mostly heart attacks or strokes. In the 1,299 patients given a placebo drug, there were 26 events. Each group, however, had the same number of deaths and not all were related to heart attacks or strokes.

"The overall number of cardiovascular events is small, but, nevertheless, the difference between the groups is significant," says Bresalier, who is professor and chair of the Department of Gastrointestinal Medicine and Nutrition at M. D. Anderson and a member of the study's steering committee.

This study
'"/>

Contact: Laura Sussman
lsussman@mdanderson.org
713-745-2457
University of Texas M. D. Anderson Cancer Center
15-Feb-2005


Page: 1 2 3

Related medicine news :

1. Researchers search for first sign of congestive heart failure
2. Researchers say breast cancer in Africa may provide clues to the disease in African-Americans
3. Researchers close in on breast cancer vaccine
4. Researchers discover link between insulin and Alzheimers
5. Researchers model brains electrical storm during a seizure
6. Researchers track programs success in curbing aggressive behavior
7. Researchers offer emergency workers a lifeline
8. Researchers discover genetic variant that may explain why women develop M.S. more than men
9. Researchers map the sexual network of an entire high school
10. Researchers hope monkeys can provide new insights into depression
11. Researchers identify the link between heart failure and weight loss

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/17/2019)... MATEO, Calif. (PRWEB) , ... September 17, 2019 ... ... the CE Mark for Europe and the 21st Century Cures Act in the ... spine surgery, radiology, and pain management. Using images from existing MRI equipment ...
(Date:9/17/2019)... ... 17, 2019 , ... Dr. Jacqueline Subka offers patients with ... A minimally invasive approach to gum surgery, laser dentistry is nearly painless and ... gentle and effective because it simply uses laser light to evaporate diseased tissue. ...
(Date:9/17/2019)... CITY, Mo. (PRWEB) , ... September 17, 2019 ... ... health providers to join the largest accountable care organization (ACO) in the country, ... to join this groundbreaking collaboration to improve care quality and increase cost efficiency. ...
(Date:9/17/2019)... ... September 17, 2019 , ... Lubin Austermuehle, P.C. ... Gather for GRIN2B will be held at Found Kitchen and Social House in ... help fund research on GRIN2B-Related Neurodevelopmental Disorder, a rare condition that results from changes ...
(Date:9/17/2019)... (PRWEB) , ... September 17, 2019 , ... ... the availability of the newly updated International Audit Protocol Consortium (IAPC) EHS audit ... audit protocols to understand the scope of their EHS regulatory obligations and rapidly ...
Breaking Medicine News(10 mins):
(Date:9/18/2019)... ... , ... Henry Ford e-Home Care has announced a significant ... Care program. Achieving monthly readmission rates as low as 7%, Henry Ford e-Home ... of 2019 by 45% compared with the prior six months of 2018. Utilizing ...
(Date:9/18/2019)... ... ... U.S. Dermatology Partners was a proud sponsor of the 9th ... The event took place at Lake Ray Hubbard in Rockwall. Over 340 swimmers raised ... money raised helps fund phase 1 clinical trials for cancer research for difficult to ...
(Date:9/17/2019)... ... 2019 , ... Scientists writing in a 2017 issue of ... progressive destruction of joint cartilage in osteoarthritis are “on the close horizon.” ... orthopedic surgeon Alejandro Badia, MD , founder and chief medical officer of ...
Breaking Medicine Technology:
Cached News: